title: Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Kagoya
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Takahashi
authors.forename: Toyoki
authors.initials: T
authors.lastname: Yoshimoto
authors.forename: Motoshi
authors.initials: M
authors.lastname: Ichikawa
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
authors.forename: Masashi
authors.initials: M
authors.lastname: Fukayama
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001344:Autopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000503:physiopathology; D054685:Lymphoma, Primary Effusion / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D010490:Pericardial Effusion / Q000188:drug therapy* / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone